Another error - the Kobe study reports a very low IFR, but the sampling methodoloy was clearly biased - they took samples from people who'd already been tested at outpatient clinics, which would obviously bias the seroprevalence upwards
-
-
-
In part, this is all worrisome because Ioannidis makes no attempt whatsoever to address any of it - these are clear and simple issues that any reasonable assessment would raise. Instead it is all accepted as truth and represented as such
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.